BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11311484)

  • 21. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane.
    Yoshimi N; Shimizu M; Matsunaga K; Yamada Y; Fujii K; Hara A; Mori H
    Jpn J Cancer Res; 1999 Apr; 90(4):406-12. PubMed ID: 10363578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
    Tanaka T; Shimizu M; Kohno H; Yoshitani S; Tsukio Y; Murakami A; Safitri R; Takahashi D; Yamamoto K; Koshimizu K; Ohigashi H; Mori H
    Life Sci; 2001 Sep; 69(16):1935-45. PubMed ID: 11693274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon.
    Al-Numair KS; Waly MI; Ali A; Essa MM; Farhat MF; Alsaif MA
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1005-11. PubMed ID: 21768165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diallyl sulfide enhances azoxymethane-induced preneoplasia in Fischer 344 rat colon.
    Delker DA; Papanikolaou A; Suhr YJ; Rosenberg DW
    Chem Biol Interact; 2000 Feb; 124(3):149-60. PubMed ID: 10728775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
    Rao CV; Kawamori T; Hamid R; Reddy BS
    Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
    Whiteley LO; Hudson L; Pretlow TP
    Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.
    Rao CV; Simi B; Reddy BS
    Carcinogenesis; 1993 Nov; 14(11):2219-25. PubMed ID: 8242846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexpected antagonistic action of 3,2'-dimethyl-4-aminobiphenyl on aberrant crypt induction by 1,2-dimethylhydrazine or azoxymethane in rat colon.
    Steffensen IL; Paulsen JE; Alexander J
    Carcinogenesis; 1995 Dec; 16(12):2981-8. PubMed ID: 8603473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats.
    Onogi N; Okuno M; Komaki C; Moriwaki H; Kawamori T; Tanaka T; Mori H; Muto Y
    Carcinogenesis; 1996 Jun; 17(6):1291-6. PubMed ID: 8681445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats.
    Liu R; Xu G
    Food Chem Toxicol; 2008 Aug; 46(8):2672-9. PubMed ID: 18571825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fischer 344 rats.
    Nozawa H; Yoshida A; Tajima O; Katayama M; Sonobe H; Wakabayashi K; Kondo K
    Int J Cancer; 2004 Jan; 108(3):404-11. PubMed ID: 14648707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oltipraz [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] on azoxymethane-induced biochemical changes related to early colon carcinogenesis in male F344 rats.
    Rao CV; Nayini J; Reddy BS
    Proc Soc Exp Biol Med; 1991 May; 197(1):77-84. PubMed ID: 2020672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifying effect of tuna orbital oil rich in docosahexaenoic acid and vitamin D3 on azoxymethane-induced colonic aberrant crypt foci in rats.
    Kohno H; Yamaguchi N; Ohdoi C; Nakajima S; Odashima S; Tanaka T
    Oncol Rep; 2000; 7(5):1069-74. PubMed ID: 10948340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP; Dolara P; Caderni G
    Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.
    Kawamori T; Takahashi M; Watanabe K; Ohta T; Nakatsugi S; Sugimura T; Wakabayashi K
    Cancer Lett; 2000 Jan; 148(1):33-7. PubMed ID: 10680590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.
    Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ
    Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention of azoxymethane-induced intestinal carcinogenesis by a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone, in rats.
    Kawamori T; Tanaka T; Suzui M; Okamoto K; Tamai Y; Torihara M; Yamahara J; Mori H
    Carcinogenesis; 1995 Apr; 16(4):795-800. PubMed ID: 7728957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents.
    Pereira MA; Barnes LH; Rassman VL; Kelloff GV; Steele VE
    Carcinogenesis; 1994 May; 15(5):1049-54. PubMed ID: 8200067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifying effects of Terminalia catappa on azoxymethane-induced colon carcinogenesis in male F344 rats.
    Morioka T; Suzui M; Nabandith V; Inamine M; Aniya Y; Nakayama T; Ichiba T; Yoshimi N
    Eur J Cancer Prev; 2005 Apr; 14(2):101-5. PubMed ID: 15785313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.